<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05611658</url>
  </required_header>
  <id_info>
    <org_study_id>525</org_study_id>
    <nct_id>NCT05611658</nct_id>
  </id_info>
  <brief_title>Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CT</brief_title>
  <official_title>Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Oncology Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Oncology Ljubljana</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate inter-observer variation in gross tumor volume (GTV)&#xD;
      delineation of oesophageal cancer on different imaging modalities - CT, PET CT and&#xD;
      MR.Twenty-three consecutive patients with esophageal cancer treated with preoperative or&#xD;
      curative chemoradiotherapy were selected. All patients had CT, PET CT and MR imaging in&#xD;
      treatment position prior to radiotherapy.Five experienced observers from our institution will&#xD;
      independently delineate GTV on CT alone, MR alone, PET CT alone, on co-registered CT and MR&#xD;
      and co-registered PET CT and MR. Inter-observer agreement, expressed in generalized&#xD;
      conformity index (CIgen) and mean volumes of GTV will be calculated per patient and imaging&#xD;
      modality.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 20, 2020</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Actual">May 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of interobserver variability in target volume delineation on CT, PET CT and MR.</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
    <description>To compare target volume delineation of esophageal cancer using CT, PET CT and MR with determining generalized conformity indexes and mean volumes of GTV.</description>
  </primary_outcome>
  <enrollment type="Actual">23</enrollment>
  <condition>Esophageal Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MR, PET CT</intervention_name>
    <description>diagnostic method</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated for esophageal cancer with preoperative or curative chemoradiotherapy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  locally advanced esophageal cancer eligible for treatment with preoperative or&#xD;
             curative chemoradiotherapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contraindications for MR&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Oncology</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>October 27, 2022</study_first_submitted>
  <study_first_submitted_qc>November 3, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2022</study_first_posted>
  <last_update_submitted>November 3, 2022</last_update_submitted>
  <last_update_submitted_qc>November 3, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

